You are here

Humira

AbbVie’s Humira Remains the Top-Selling Prescription for 2018

Biopharma Dive

Wed, 03/13/19 - 01:02 pm

prescription data

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study

BioSpace

Mon, 03/11/19 - 10:25 am

ulcerative colitis

AbbVie and Pfizer return to the top of pharma's TV spending list for February

Fierce Pharma

Wed, 03/6/19 - 11:36 am

Hand over your Humira biosim launch plans; judge tells Boehringer in AbbVie patent fight

Fierce Pharma

Wed, 02/27/19 - 12:06 pm

Boehringer Ingelheim

Why Abbvie May Have A Tough Time Defending Humira's Price Before Congress

Forbes

Tue, 02/26/19 - 09:35 am

pharma executives

AbbVie’s JAK inhibitor upadacitinib gets Priority Review

Pharmaforum

Wed, 02/20/19 - 11:23 am

priority review

rheumatoid arthritis

AbbVie loses bid to hoard documents in Humira patent fight with Boehringer

Fierce Pharma

Mon, 02/11/19 - 12:21 pm

Boehringer Ingelheim

Forget Humira -- Here's What You Need to Know About AbbVie

Motley Fool

Sun, 01/27/19 - 12:13 pm

AbbVie loses $8B in market cap on steeper Humira erosion

BioCentury

Fri, 01/25/19 - 11:20 pm

Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate

CP Wire

Fri, 01/25/19 - 11:53 am

Coherus Biosciences

Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate

Fri, 01/25/19 - 10:41 am

Coherus Biosciences

AbbVie profit misses as Humira faces biosimilar challenge in Europe

Yahoo/Reuters

Fri, 01/25/19 - 10:14 am

3 Big Reasons Why AbbVie Isn't Worried About Humira

Yahoo/Motley Fool

Thu, 01/10/19 - 09:47 am

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial

Reuters

Mon, 12/17/18 - 08:15 pm

psoriatic arthritis

clinical trials

AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023

Fierce Pharma

Fri, 11/30/18 - 12:36 pm

Why Abbvie Is Down 5% in 2018 So Far

Motley Fool

Sat, 11/17/18 - 12:44 pm

7 drugs that raised eyebrows in Q3

Biopharma Dive

Thu, 11/15/18 - 11:50 pm

Clovis Oncology

Boehringer Cites ‘Massive’ Number of Patents in Humira Biosimilar Suit

RAPS.org

Fri, 11/9/18 - 11:34 am

Boehringer Ingelheim

AbbVie staves off 6th Humira biosimilar in US

Biopharma Dive

Wed, 11/7/18 - 10:44 pm

Momenta Pharmaceuticals

AbbVie says global Humira market eroding faster than expected

BioCentury

Fri, 11/2/18 - 07:55 pm

Pages